Skip to main content
British Journal of Cancer logoLink to British Journal of Cancer
. 1978 Nov;38(5):624–630. doi: 10.1038/bjc.1978.259

Survival and recurrences five years after selective treatment for breast carcinoma.

H O Adami, S Graffman, H Johansson, A Rimsten
PMCID: PMC2009785  PMID: 728351

Abstract

110 consecutively diagnosed breast-cancer patients in all stages were included in a study to evaluate a selective surgical and radiotherapeutical treatment. The surgical treatment was total mastectomy and exploration of the axilla, with lymphnode biopsy and peroperative cytological examination. Axillary dissection was done only when this examination showed metastases. No radiotherapy was given to the axilla in patients with lateral cancers in the absence of metastases, or with limited metastasization (no periglandular growth, no growth in apical nodes). In medial and central cancers, radiotherapy was applied to the parasternal and supraclavicular nodes irrespective of axillary involvement. A staging system with a combined clinical and histopathological classification was used and formed the basis for the selective treatment. The corrected 5-year survival for the whole material was 80%, for those without axillary metastasis (Stage I) 95% and for those with axillary metastasis (Stage II) 68%. Six women were alive with known distant metastases. Of 63 patients without identified axillary metastases at the time of surgery, axillary recurrences occurred in only 3 (5%). It was concluded that patients without axillary metastases can be reliably selected by the peroperative examination used, and that in this group simple mastectomy results in a high disease-free survival. Early diagnosis and a possible beneficial effect of the actual therapeutic programme might both have contributed to the high overall survival.

Full text

PDF
624

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adami H., Johansson H., Rimsten A., Thorén L. Hur diagnostiseras och behandlas bröstcancer i Sverige? Lakartidningen. 1976 Oct 5;73(41):3434–3437. [PubMed] [Google Scholar]
  2. Anglem T. J., Leber R. E. Characteristics of ten year survivors after radical mastectomy for cancer of the breast. Am J Surg. 1971 Apr;121(4):363–367. doi: 10.1016/0002-9610(71)90223-6. [DOI] [PubMed] [Google Scholar]
  3. Finney G. G., Merkel W. C., Miller D. B. Carcinoma of the Breast: A Study of 298 Consecutive Cases. Ann Surg. 1947 Jun;125(6):673–687. doi: 10.1097/00000658-194706000-00001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Fisher B. The present status of tumor immunology. Adv Surg. 1971;5:189–254. [PubMed] [Google Scholar]
  5. Forrest A. P., Roberts M. M., Preece P., Henk J. M., Campbell H., Hughes L. E., Desai S., Hulbert M. The Cardiff-St Mary's trial. Br J Surg. 1974 Oct;61(10):766–769. doi: 10.1002/bjs.1800611005. [DOI] [PubMed] [Google Scholar]
  6. Freund H., Durst A. L., Grover N. B., Komissar G., Petersburg I., Saltz N. J. Radical mastectomy for operable breast cancer. J Surg Oncol. 1977;9(5):487–492. doi: 10.1002/jso.2930090511. [DOI] [PubMed] [Google Scholar]
  7. Graffman S., Jung B. Clinical trials in radiotherapy and the merits of high energy protons. Acta Radiol Ther Phys Biol. 1970 Feb;9(1):1–23. [PubMed] [Google Scholar]
  8. Johansson H., Rimsten A., Stenkvist B., Danielsson J. Organization of a breast tumour clinic and aspects of data analysis of a clinical material. Scand J Soc Med. 1975;3(2):75–82. doi: 10.1177/140349487500300205. [DOI] [PubMed] [Google Scholar]
  9. Kirk J., Gray W. M., Watson E. R. Cumulative radiation effect. I. Fractionated treatment regimes. Clin Radiol. 1971 Apr;22(2):145–155. doi: 10.1016/s0009-9260(71)80044-2. [DOI] [PubMed] [Google Scholar]
  10. Madden J. L., Kandalaft S., Bourque R. A. Modified radical mastectomy. Ann Surg. 1972 May;175(5):624–634. doi: 10.1097/00000658-197205000-00002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Payne W. S., Taylor W. F., Khonsari S., Snider J. H., Harrison E. G., Jr, Golenzer H., Clagett O. T. Surgical treatment of breast cancer. Trends and factors affecting survival. Arch Surg. 1970 Aug;101(2):105–113. doi: 10.1001/archsurg.1970.01340260009002. [DOI] [PubMed] [Google Scholar]
  12. Rimsten A., Johansson H., Stenkvist B. Peroperative diagnosis of axillary lymph nodes in cancer of the breast. Surg Gynecol Obstet. 1974 Oct;139(4):551–554. [PubMed] [Google Scholar]
  13. Rimsten A., Johansson H., Stenkvist B., Thelin A. M. Axillary recurrences after selective treatment of the axillary nodes in cancer of the breast. Clin Oncol. 1976 Dec;2(4):357–364. [PubMed] [Google Scholar]
  14. Rimsten A., Stenkvist B., Johanson H., Lindgren A. The diagnostic accuracy of palpation and fine-needle biopsy and an evaluation of their combined use in the diagnosis of breast lesions: report on a prospective study in 1244 women with symptoms. Ann Surg. 1975 Jul;182(1):1–8. doi: 10.1097/00000658-197507000-00001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Schottenfeld D., Nash A. G., Robbins G. F., Beattie E. J., Jr Ten-year results of the treatment of primary operable breast carcinoma: A summary of 304 patients evaluated by the TNM system. Cancer. 1976 Aug;38(2):1001–1007. doi: 10.1002/1097-0142(197608)38:2<1001::aid-cncr2820380252>3.0.co;2-5. [DOI] [PubMed] [Google Scholar]
  16. Silverberg S. G. Staging in the therapy of cancer of the breast. Am J Clin Pathol. 1975 Dec;64(6):756–763. doi: 10.1093/ajcp/64.6.756. [DOI] [PubMed] [Google Scholar]
  17. Stjernswärd J. Decreased survival related to irradiation postoperatively in early operable breast cancer. Lancet. 1974 Nov 30;2(7892):1285–1286. doi: 10.1016/s0140-6736(74)90142-1. [DOI] [PubMed] [Google Scholar]
  18. URBAN J. A. Treatment of early cancer of the breast. Postgrad Med. 1960 Mar;27:389–393. doi: 10.1080/00325481.1960.11712851. [DOI] [PubMed] [Google Scholar]
  19. Wallace I. W., Champton H. R. Axillary nodes in breast cancer. Lancet. 1972 Jan 29;1(7744):217–218. doi: 10.1016/s0140-6736(72)90619-8. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES